Zobrazeno 1 - 10
of 52
pro vyhledávání: '"He Ren"'
Autor:
Xiaofan Guo, Zhiqiang Chen, Shuai Yuan, Bodong Zhou, Yifei Wang, Jihui Hao, Song Gao, He Ren, Jin Ren, Yizhang Zhou
Publikováno v:
Pancreatology. 21:763-770
Background FOLFIRINOX and gemcitabine plus albumin-bound paclitaxel (AG) regimens are recommended as first-line therapy for both locally advanced and metastatic pancreatic cancer. However, there were no specific markers to conduct personalized regime
Publikováno v:
Cancer Biology & Medicine
Cancer Biology & Medicine, Vol 18, Iss 4, Pp 937-939 (2021)
Cancer Biology & Medicine, Vol 18, Iss 4, Pp 937-939 (2021)
Autor:
Yingjiang Liu, Qian Ran, Chengxuan Liu, He Ren, Cong Peng, Qinqin Hu, Yang Jiang, Ling Zhang, Tianyou Luo, Xiuting Mei, Renrong Liang, Yu Fang, Hua Yang, Yi Cao
Publikováno v:
Clinical Neuroradiology. 31:373-381
To investigate cerebral amplitude of low-frequency fluctuations (ALFF) changes during a single hemodialysis (HD) in end-stage renal disease (ESRD) patients who need maintenance HD. A total of 24 patients and 27 healthy subjects were included. The pat
Autor:
He Ren, Jihui Hao, Xiuchao Wang, Hongwei Wang, Weiwei Bai, Chongbiao Huang, Wenna Jiang, Wenwen Yu, Bo Yang, Jing Liu, Shengyu Yang, Kaili Zhao, Danqi Fu, Tai Qin, Tianxing Zhou, Wei Tan, Xin Li, Tiansuo Zhao, Song Gao
Publikováno v:
The Journal of Experimental Medicine
EHF transcriptionally inhibits the expressions of TGFβ1 and GM-CSF to decrease T reg cell and MDSC accumulation, making it a promising biomarker to evaluate the immune microenvironment in PDAC. EHF overexpression may improve the efficacy of checkpoi
Autor:
He Ren, Ruining Gong
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 5, Iss 1, Pp 1-2 (2020)
Signal Transduction and Targeted Therapy
Signal Transduction and Targeted Therapy
Programmed cell death 1 (PD-1) inhibitors have limited effect in pancreatic ductal adenocarcinoma (PDAC), underscoring the need to co-target alternative pathways. CXC chemokine receptor 4 (CXCR4) blockade promotes T cell tumor infiltration and is syn
Autor:
Xunbin Wei, Han Wang, He Ren, Caijuan Tian, Jihui Hao, Jiangyan Zhang, Yanhui Yang, Zanmei Xu, Xin Li, Haiping Jiang, Xiuchao Wang, Shengyu Yang, Chungen Lan
Publikováno v:
Signal Transduction and Targeted Therapy
Signal Transduction and Targeted Therapy, Vol 5, Iss 1, Pp 1-12 (2020)
Signal Transduction and Targeted Therapy, Vol 5, Iss 1, Pp 1-12 (2020)
High expression of PD-L1 marks the poor prognosis of pancreatic ductal adenocarcinomas (PDAC). However, the regulatory mechanism of PD-L1 remains elusive. We recently reported that cancer Forkhead box protein 3 (Cancer-FOXP3 or C-FOXP3) promoted immu
Autor:
Yan Peng, Xiao-Yan He, Si-Xue Cheng, Jian-Ping Zhang, Shu-Lun Ai, Bo-Ya Liu, Chang Xu, Xiao-He Ren
Publikováno v:
Advanced materials (Deerfield Beach, Fla.). 32(17)
Effective reversal of tumor immunosuppression is of critical importance in cancer therapy. A multifunctional delivery vector that can effectively deliver CRISPR-Cas9 plasmid for β-catenin knockout to reverse tumor immunosuppression is constructed. T
Publikováno v:
ACS applied materialsinterfaces. 11(42)
To enhance the treatment efficiency in tumor therapy, we developed a tumor-targeting protein-based delivery system, DOX&ICG@BSA-KALA/Apt, to efficiently integrate multimodal therapy with tumor imaging and realize synchronous photodynamic therapy/phot
Autor:
Rui-Rui Sang, Huan Liu, Chun-Chen Yang, Lai Wei, Mi Jiang, Shun Liu, He Ren, Le-Ye Wang, Rong Zhou, Ruiming Rong, Xing-Qiu Xia
Publikováno v:
Ann Transl Med
BACKGROUND: Red blood cell (RBC) transfusion therapy has been widely used in surgery, and has yielded excellent treatment outcomes. However, in some instances, the demand for RBC transfusion is assessed by doctors based on their experience. In this s
Autor:
He Ren, Wei Zhang, Chongbiao Huang, Na Li, Lin Luo, Zengxun Li, Antao Chang, Yang Li, Xiuchao Wang, Shengyu Yang, Yanan Chen, Tiansuo Zhao, Zhimin Wang, Jingjing Shi, Jihui Hao
Publikováno v:
Nature Communications, Vol 8, Iss 1, Pp 1-15 (2017)
Nature Communications
Nature Communications
Interleukin 35 (IL-35) is a novel member of the IL-12 family, consisting of an EBV-induced gene 3 (EBI3) subunit and a P35 subunit. IL-35 is an immune-suppressive cytokine mainly produced by regulatory T cells. However, the role of IL-35 in cancer me